Literature DB >> 12011020

Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.

Lolke De Haan1, Arron R Hearn, A Jennifer Rivett, Timothy R Hirst.   

Abstract

Current immunization strategies, using peptide or protein antigens, generally fail to elicit cytotoxic-T-lymphocyte responses, since these antigens are unable to access intracellular compartments where loading of major histocompatibility complex class I (MHC-I) molecules occurs. In an attempt to circumvent this, we investigated whether the GM1 receptor-binding B subunit of Escherichia coli heat-labile toxin (EtxB) could be used to deliver class I epitopes. When a class I epitope was conjugated to EtxB, it was delivered into the MHC-I presentation pathway in a GM1-binding-dependent fashion and resulted in the appearance of MHC-I-epitope complexes at the cell surface. Importantly, we show that the efficiency of EtxB-mediated epitope delivery could be strikingly enhanced by incorporating, adjacent to the class I epitope, a 10-amino-acid segment from the C terminus of the DNA polymerase (Pol) of herpes simplex virus. The replacement of this 10-amino-acid segment by a heterologous sequence or the introduction of specific amino acid substitutions within this segment either abolished or markedly reduced the efficiency of class I epitope delivery. If the epitope was extended at its C terminus, EtxB-mediated delivery into the class I presentation pathway was found to be completely dependent on proteasome activity. Thus, by combining the GM1-targeting function of EtxB with the 10-amino-acid Pol segment, highly efficient delivery of exogenous epitopes into the endogenous pathway of class I antigen processing and presentation can be achieved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011020      PMCID: PMC128024          DOI: 10.1128/IAI.70.6.3249-3258.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  Cut and trim: generating MHC class I peptide ligands.

Authors:  J W Yewdell; J R Bennink
Journal:  Curr Opin Immunol       Date:  2001-02       Impact factor: 7.486

2.  Secondary structure and structure-activity relationships of peptides corresponding to the subunit interface of herpes simplex virus DNA polymerase.

Authors:  K G Bridges; Q Hua; M R Brigham-Burke; J D Martin; P Hensley; C E Dahl; P Digard; M A Weiss; D M Coen
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

3.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 4.  Degradation of cell proteins and the generation of MHC class I-presented peptides.

Authors:  K L Rock; A L Goldberg
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

5.  Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin.

Authors:  R S Lee; E Tartour; P van der Bruggen; V Vantomme; I Joyeux; B Goud; W H Fridman; L Johannes
Journal:  Eur J Immunol       Date:  1998-09       Impact factor: 5.532

Review 6.  Fully mobilizing host defense: building better vaccines.

Authors:  S Raychaudhuri; K L Rock
Journal:  Nat Biotechnol       Date:  1998-11       Impact factor: 54.908

7.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.

Authors:  L Meng; R Mohan; B H Kwok; M Elofsson; N Sin; C M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

8.  Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses.

Authors:  O Samuel; Y Shai
Journal:  Biochemistry       Date:  2001-02-06       Impact factor: 3.162

9.  Roles of Glu 349 and Asp 352 in membrane insertion and translocation by diphtheria toxin.

Authors:  P Kaul; J Silverman; W H Shen; S R Blanke; P D Huynh; A Finkelstein; R J Collier
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

10.  Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  A Loregian; E Papini; B Satin; H S Marsden; T R Hirst; G Palù
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

View more
  15 in total

1.  Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.

Authors:  Juliette K Tinker; Chadwick T Davis; Britni M Arlian
Journal:  Protein Expr Purif       Date:  2010-05-11       Impact factor: 1.650

2.  Antigen delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation.

Authors:  Suzanne Flanary; Allan S Hoffman; Patrick S Stayton
Journal:  Bioconjug Chem       Date:  2009-02       Impact factor: 4.774

3.  Promotion of CTL epitope presentation by a nanoparticle with environment-responsive stability and phagolysosomal escape capacity.

Authors:  Shuyun Dong; Sundharraman Subramanian; Kristin N Parent; Mingnan Chen
Journal:  J Control Release       Date:  2020-09-19       Impact factor: 9.776

4.  The B subunit of Escherichia coli heat-labile toxin alters the development and antigen-presenting capacity of dendritic cells.

Authors:  Jing Ji; Kristin L Griffiths; Peter J Milburn; Timothy R Hirst; Helen C O'Neill
Journal:  J Cell Mol Med       Date:  2015-07-01       Impact factor: 5.310

5.  The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A.

Authors:  Beatrice Ondondo; Lee Faulkner; Neil A Williams; Andrew J Morgan; David J Morgan
Journal:  Cancer Med       Date:  2015-02-02       Impact factor: 4.452

6.  E. coli Heat-labile Enterotoxin B Subunit as a Platform for the Delivery of HIV Gag p24 Antigen.

Authors:  Karmarcha Martin; Toufic O Nashar
Journal:  J Clin Cell Immunol       Date:  2013-04-23

7.  Escherichia coli Heat-Labile Enterotoxin B Limits T Cells Activation by Promoting Immature Dendritic Cells and Enhancing Regulatory T Cell Function.

Authors:  Alexandre Bignon; Alan P Watt; Michelle A Linterman
Journal:  Front Immunol       Date:  2017-05-15       Impact factor: 7.561

8.  Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions.

Authors:  Sylvia A Fraser; Lolke de Haan; Arron R Hearn; Heather K Bone; Robert J Salmond; A Jennifer Rivett; Neil A Williams; Timothy R Hirst
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

9.  The B subunit of Escherichia coli heat-labile enterotoxin enhances CD8+ cytotoxic-T-lymphocyte killing of Epstein-Barr virus-infected cell lines.

Authors:  Kong-Wee Ong; A Douglas Wilson; Timothy R Hirst; Andrew J Morgan
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant.

Authors:  Ignazio Castagliuolo; Marina Sardina; Paola Brun; Chiara DeRos; Cristina Mastrotto; Laura Lovato; Giorgio Palù
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.